share_log

海王英特龍(08329.HK)附屬「海王福藥」遭申索逾1.5億人幣

"Haiwang Fu Medicine" affiliated to Sea King 08329.HK has been claimed for more than 150 million yuan.

即市頭條 ·  Dec 8, 2021 21:20

Haiwang Interlon (08329.HK) announced that Haiwangfu Pharmaceutical, an 80%-owned subsidiary of the company, has recently been claimed by Beijing Yiling Pharmaceutical Science and Technology Development to the Beijing Court for the rescission of the Agreement on Application, Patent Licensing, production and sales Management of Cardiac Protective cardioplegia (Hutkin) signed by both parties in 2019. It also asked Haiwang Fuyao to pay Beijing Yiling Pharmaceutical Technology a total of more than 150 million yuan in market losses and liquidated damages, as well as the litigation costs of the case.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment